TAILIEUCHUNG - Medicines Adherence: involving patients in decisions about prescribed medicines and supporting

Secondary prevention refers to the detection and management of presympto- matic disease, and the prevention of its progression to symptomatic disease. Screening is the dominant practice in this space, exemplified by cancer screening (., mammography, colonoscopy), and cardiac risk screening (., lipid testing, blood pressure screens). The margins between primary and secondary prevention can at times blur, depending on definitions used for diseases, their risks, and their antecedents. If hypertension is defined as a disease, its treatment is secondary prevention; if defined as a risk factor for coronary disease that does not yet exist, it is primary prevention. Presymptomatic diagnosis. | Medicines Adherence involving patients in decisions about prescribed medicines and supporting adherence Full Guideline January 2009 National Collaborating Centre for Primary Care Royal College of General Practitioners Citation Nunes V Neilson J O Flynn N Calvert N Kuntze S Smithson H Benson J Blair J Bowser A Clyne W Crome P Haddad P Hemingway S Horne R Johnson S Kelly S Packham B Patel M Steel J 2009 . Clinical Guidelines and Evidence Review for Medicines Adherence involving patients in decisions about prescribed medicines and supporting adherence. London National Collaborating Centre for Primary Care and Royal College of General Practitioners. ROYAL COLLEGE OF GENERAL PRACTITIONERS 14 Princes Gate Hyde Park London SW7 1PU Registered charity No 223106 Copyright 2009 Royal College of General Practitioners All rights reserved. No part of this publication may be reproduced in any form including photocopying or storing it in any medium by electronic means andwhether or not transiently or incidentally to some other use of this publication without the written permission of the copyright owner. Applications for the copyright owner s written permission to reproduce any part of this publication should be addressed to the publisher. i Table of Contents 1 Aim of the How the guideline is set Guideline Responsibility and support for guideline Research Glossary . 31 2 Methods .38 Introduction. 38 Developing key clinical questions KCQs . 38 Literature search strategy . 39 Identifying the evidence . 42 Critical appraisal of the evidence. 42 Health Economics methods . 43 Forming recommendations . 45 Areas without evidence and consensus methodology . 46 Update .46 Consultation. 46 Relationships between the guideline and other national guidance .47 .

• Y học thường thức
• multiple medicines
• following guidance
• recommendations
• Alumina Carrier
• Titanium Dioxide
• Dioxide Photocatalyst
• recommendation
• including existing
• pharmaceutical policies
• market situations
• organ donation
• donors includes
• direct reimbursement
• Harnessing opportunities
• Integrated approach
• Cooperation at multiple levels